Scientists Map Genetic Evolution Of Leukaemia Through MDS Patients
Here is a new article by the Washington University in St. Louis, School of Medicine:
This article deals with the need to develop cancer drugs that target specific gene mutations that develop in MDS.
Introduction: “By mapping the evolution of cancer cells in patients with myelodysplastic syndromes who later died of leukemia, Timothy Graubert, MD, and Matthew Walter, MD, from the Washington University in St. Louis, School of Medicine, have found clues to suggest that targeted cancer drugs should be aimed at mutations that develop early in the disease.”
Read the full article, published 14/03/2012, here.











A visitor to King’s looks at pictures of Niels Jensen, an MDS patient from Denmark. To the left, photos of MDS patient Rosmary Pauer from Canada are displayed.
The exhibition has helped raise awareness of MDS and the MDS UK Patient Support Group. Visitors to the exhibition can take information materials including leaflets and newsletters.